An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Back Pain Lower Back Chronic
Interventions
DRUG

Duloxetine

Administered orally

Trial Locations (1)

330-0063

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Saitama

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shionogi

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY